Influenza

FDA panel deciding on safety of flu spray

Published in Vaccine Weekly, January 15th, 2003

The manufacturer of the first pain-free flu vaccine seeks to ease federal scientists' safety concerns by withdrawing its attempt to market the product to children under 5 years old.

A U.S. Food and Drug Administration committee was considering whether to recommend approval of MedImmune, Inc.'s FluMist, a nasal spray.

The big issue is just how safe FluMist is, because the nasal vaccine is made with live flu virus instead of the killed virus in today's flu shots.

In July 2001, the FDA's advisers said FluMist hadn't proved safe enough to sell yet.

December 17, 2002, MedImmune argued its case again, this time...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2003-01-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry